Merck inaugurates its Global Capability Centre in Bengaluru, enhancing digital innovation and collaboration across its global ...

Candel Therapeutics has appointed Mark Sims as Chief Commercial Officer, effective 6 July 2026. Sims is a seasoned oncology ...

Discover how Merck's new Bengaluru hub is leading AI innovation. Learn more about its impact on digital transformation and ...

The "Mad Money" host revisits a stock he spent years dismissing.

Merck opens GCC in Bengaluru to advance digital transformation and enterprise innovation: Our Bureau, Bengaluru Monday, June 29, 2026, 16:45 Hrs [IST] Merck, a science and technol ...

A bipartisan group of United States lawmakers has opened national security investigations into whether five major ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Replimune Group, Inc. nears a pivotal FDA AdCom for RP1 ahead of an Aug 2, 2026 decision. Click for this REPLY stock update ...

Are animal welfare and economics always at odds? Not necessarily, say the founders of new venture studio Spring Innovation ...

These 8 healthcare stocks delivered strong gains last week. Discover what drove each rally—and why not all rallies are ...

Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.

UK-based BioPhorum today announced the formation of the Synthetic Molecule Process Innovation Phorum, uniting an ecosystem of 20 leading organizations to urgently address the rapidly accelerating pace ...